Previous close | 3.2600 |
Open | 3.2400 |
Bid | 3.3300 x 100 |
Ask | 3.4200 x 100 |
Day's range | 3.2400 - 3.4300 |
52-week range | 2.9800 - 13.8500 |
Volume | |
Avg. volume | 133,003 |
Market cap | 141.732M |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.2300 |
Earnings date | 26 Feb 2024 - 01 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 15.33 |
Key Insights Significant control over Repare Therapeutics by private equity firms implies that the general public has...
Repare Therapeutics ( NASDAQ:RPTX ) Full Year 2023 Results Key Financial Results Revenue: US$51.1m (down 61% from FY...
CAMBRIDGE, Mass. & MONTREAL, February 29, 2024--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two upcoming investor conferences. Details for the presentations are as follows.